Clinical trials
Phase 3 Endometrial Neoplasms trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 5 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 9 |
| Recruiting | 6 |
| Completed | 3 |
| Unknown status | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 5 |
| AstraZeneca | 3 |
| National Cancer Institute (NCI) | 2 |
| ARCAGY/ GINECO GROUP | 1 |
| Advenchen Laboratories, LLC | 1 |
| BioNTech SE | 1 |
| Daiichi Sankyo | 1 |
| Eisai Inc. | 1 |
| Gilead Sciences | 1 |
| GlaxoSmithKline | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Endometrial Neoplasms | 20 |
| Neoplasms | 3 |
| Neoplasm Metastasis | 2 |
| Uterine Neoplasms | 2 |
| Carcinosarcoma | 1 |
| Fallopian Tube Neoplasms | 1 |
| Ovarian Neoplasms | 1 |
| Uterine Cervical Neoplasms | 1 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.